Screener
Monte Rosa Therapeutics, Inc. GLUE Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Monte Rosa Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
FAQ
- What is Monte Rosa Therapeutics, Inc.'s price / book?
- Monte Rosa Therapeutics, Inc. (GLUE) reported price / book of 4.2× in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s price / book changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s price / book increased by 285.8% year-over-year, from 1.1× to 4.2×.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s price / book?
- Over 4 years (2021 to 2025), Monte Rosa Therapeutics, Inc.'s price / book has grown at a 12.5% compound annual growth rate (CAGR), from 2.7× to 4.4×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Monte Rosa Therapeutics, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude